A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type’s molecular idiosyncrasies.
The study, published August 23, 2013 in the online version of the journal Cancerby researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (BWH), is the first to compare the spectrum of cancer-related gene mutations in the two main subtypes of cervical cancer — adenocarcinoma and squamous cell carcinoma.
Share this article
Read the full, original story here: Genomic Differences Found in Types of Cervical Cancer
